Low‐grade prostate cancer diverges early from high grade and metastatic disease von VanderWeele, David J., Brown, Christopher D., Taxy, Jerome B., Gillard, Marc, Hatcher, David M., Tom, Westin R., Stadler, Walter M., White, Kevin P.

Volltext

Effect of Laser Settings and Irrigation Rates on Ureteral Temperature During Holmium Laser Lithotripsy, an In Vitro Model von Wollin, Daniel A, Carlos, Evan C, Tom, Westin R, Simmons, W Neal, Preminger, Glenn M, Lipkin, Michael E

Volltext

Next-Generation Single-Use Ureteroscopes: An In Vitro Comparison von Tom, Westin R, Wollin, Daniel A, Jiang, Ruiyang, Radvak, Daniela, Simmons, Walter Neal, Preminger, Glenn M, Lipkin, Michael E

Volltext

Assessment of conservative dietary management as a method for normalization of 24-h urine pH in stone formers von Wollin, Daniel A., Davis, Leah G., Winship, Brenton B., Carlos, Evan C., Tom, Westin R., Asplin, John R., Kosinski, Andrzej S., Scales, Charles D., Ferrandino, Michael N., Preminger, Glenn M., Lipkin, Michael E.

Volltext

Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue von Gillard, Marc, Tom, Westin R, Antic, Tatjana, Paner, Gladell P, Lingen, Mark W, VanderWeele, David J

Volltext

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma von Locke, Frederick L, Miklos, David B, Jacobson, Caron A, Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O, Ghobadi, Armin, Rapoport, Aaron P, McGuirk, Joseph, Pagel, John M, Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M, Sureda, Anna, Flinn, Ian W, Vandenberghe, Peter, Song, Kevin W, Dickinson, Michael, Minnema, Monique C, Riedell, Peter A, Leslie, Lori A, Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I, Westin, Jason R

Volltext

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines fo... von Kyle, R A, Durie, B G M, Rajkumar, S V, Landgren, O, Blade, J, Merlini, G, Kröger, N, Einsele, H, Vesole, D H, Dimopoulos, M, San Miguel, J, Avet-Loiseau, H, Hajek, R, Chen, W M, Anderson, K C, Ludwig, H, Sonneveld, P, Pavlovsky, S, Palumbo, A, Richardson, P G, Barlogie, B, Greipp, P, Vescio, R, Turesson, I, Westin, J, Boccadoro, M

Volltext

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma von Westin, Jason R, Locke, Frederick L, Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David B, Ulrickson, Matthew L, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori, Kersten, Marie José, Jacobson, Caron A, Pagel, John M, Wulf, Gerald, Johnston, Patrick, Rapoport, Aaron P, Du, Linqiu, Vardhanabhuti, Saran, Filosto, Simone, Shah, Jina, Snider, Julia T, Cheng, Paul, To, Christina, Oluwole, Olalekan O, Sureda, Anna

Volltext

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma von Locke, Frederick L., Miklos, David B., Jacobson, Caron A., Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O., Ghobadi, Armin, Rapoport, Aaron P., McGuirk, Joseph, Pagel, John M., Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M., Sureda, Anna, Flinn, Ian W., Vandenberghe, Peter, Song, Kevin W., Dickinson, Michael, Minnema, Monique C., Riedell, Peter A., Leslie, Lori A., Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I., Westin, Jason R.

Volltext

SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL von Westin, J., Strati, P., Chihara, D., Pulsifer, B., Tom, J., Davis, R. E., Lee, H. J., Nair, R., Rodriguez, A., Hagemeister, F., Flowers, C., Nastoupil, L., Feng, L., Green, M., Fayad, L., Iyer, S., Ahmed, S., Steiner, R.

Volltext

1 - Primary Analysis of Zuma-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients with Relapsed/Refractory Large B-C... von Locke, Frederick L., Miklos, David B., Jacobson, Caron A., Perales, Miguel-Angel, Kersten, Marie José, Oluwole, Olalekan O., Ghobadi, Armin, Rapoport, Aaron P., McGuirk, Joseph P., Pagel, John M., Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M., Sureda, Anna, Flinn, Ian W., Vandenberghe, Peter, Song, Kevin W., Dickinson, Michael, Minnema, Monique C., Riedell, Peter A., Leslie, Lori A., Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I., Westin, Jason R.

Volltext